GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $29,513,000 | +7.3% | 264,098 | +27.4% | 0.01% | -16.7% |
| Q3 2016 | $27,511,000 | +51.8% | 207,274 | +4.7% | 0.01% | +50.0% |
| Q2 2016 | $18,121,000 | +26.1% | 197,888 | -0.7% | 0.00% | +33.3% |
| Q1 2016 | $14,376,000 | +19.3% | 199,247 | +14.9% | 0.00% | 0.0% |
| Q4 2015 | $12,047,000 | -37.6% | 173,481 | -17.9% | 0.00% | -40.0% |
| Q3 2015 | $19,317,000 | +2.5% | 211,420 | +37.8% | 0.01% | 0.0% |
| Q2 2015 | $18,852,000 | +40.7% | 153,470 | +4.4% | 0.01% | +66.7% |
| Q1 2015 | $13,394,000 | +42.2% | 146,982 | +5.6% | 0.00% | +50.0% |
| Q4 2014 | $9,420,000 | – | 139,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |